Evidence to Use in Primary Care

Short on time? Read the In Brief

Short on time? Read the In Brief.

Short on time? Read the In Brief.

Short on time? Read the In Brief .

Short on time? Read the Report in Brief.
 

Short on time? Read the In Brief.

Short on time? Read the In Brief.

Short on time? Read the In Brief.

Short on time? Read the In Brief.

Short on time? Read the In Brief.

Short on time? Read the In Brief.

Short on time? Read the In Brief.

Short on time? Read the In Brief.

Short on time? Read the In Brief.

This summary tool summarizes findings from a literature review that evaluated the published evidence on artificial intelligence (AI) for the prevention, diagnosis, and treatment of mental health illnesses. It also summarizes findings on the clinical effectiveness of AI applications, purpose of use, patient populations, primary users, and related evidence-based guidelines.

A summary of the evidence (based on a number of CADTH reviews) on codeine for pain.

To help support decisions about managing pain, CADTH has been reviewing the evidence on different treatment options for various types of pain. Here, you’ll find the highlights of many of these evidence reviews.

Over the last few years, CADTH has been asked to review, the clinical effectiveness evidence and the recommendations from evidence-based guidelines for treating various acute pain conditions with non-pharmacological interventions. Here, you’ll find the evidence highlights related to those evidence reviews.

Resources for people living with chronic pain and resources for clinicians.

Tips and resources for determining whether a health website contains reliable health information

Highlights from the CADTH Optimal Use project that assessed the clinical effectiveness, cost-effectiveness, patients’ perspectives and experiences, ethical considerations, and implementation issues associated with HPV testing for primary cervical cancer screening.

Evidence Highlights

This two-page, quick-reference map provides information on publicly funded take-home naloxone programs for the provinces, territories, and federal drug plans. This tool also outlines what naloxone is, who is at risk of an opioid overdose, and what can be found in a take-home naloxone kit.

CADTH partnered with the New Brunswick Department of Health, New Brunswick Medical Society, and Choosing Wisely New Brunswick to create this module on opioid prescribing. The module provides an overview of the New Brunswick Prescription Monitoring Program and addresses the management of acute low back pain.

A summary of five CADTH reports, published between 2014 and 2018, on gabapentin for neuropathic pain.

Provides suggested lifestyle modifications and basic management strategies for GI conditions in an easy-to-print, one-page handout.

Hospital News Article (May 1, 2019)

(Hospital News article, June 2, 2021)

Hospital News Article (September 4, 2018)

(Webinar, November 1, 2019)

(Hospital News article, August 26, 2021)

On November 27, 2019, CADTH hosted a national Evidence to Action event to introduce evidence reviews led by CADTH and Health Quality Ontario and to discuss the use and implementation of internet-delivered cognitive behavioural therapy (iCBT) for major depression and anxiety disorders in Canada. In the event, Karilyn Xu (student at York University and iCBT user) , Dr. David Gratzer (Psychiatrist at the Centre for Addiction and Mental Health, and Associate Chief of the General Adult Psychiatry and Health Systems Division), Patrick Mitchell (Director of the Mental Health and Addictions Policy, Accountability and Provincial Partnership at the Ontario Ministry of Health), and Dr. Heather Hadjistavropoulos (Professor in the Department of Psychology at the University of Regina and Founder and Director of the Online Therapy Unit in Saskatchewan) shared their perspectives on using and implementing iCBT for these conditions in Canada.

Hospital News Article (November 19, 2019)

(Hospital News article, June 30, 2021)

(Hospital News article, October 6, 2021)